Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure
Open Access
- 15 April 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (8) , 1423-1429
- https://doi.org/10.1016/j.jacc.2003.11.037
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- Ambulatory blood pressure monitoring of patients with heart failure: a new prognosis markerArquivos Brasileiros de Cardiologia, 2002
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.Circulation, 1989
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failureThe American Journal of Medicine, 1963